Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a.
Tola
Maria Rosaria
MR
Caniatti
Luisa Maria
LM
Gragnaniello
Daniela
D
Russo
Monia
M
Stabellini
Nevio
N
Granieri
Enrico
E
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000209:etiology*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a